Suchergebnisse - "Fréchet-Jachym, Mathilde"

PubPharm (22)

1

Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Eimer, J. | Fréchet-Jachym, M. | Le Dû, D. | +30

2

Availability and costs of medicines for the treatment of tuberculosis in Europe

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Günther, G. | Guglielmetti, L. | Leu, C. | +87

3

Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006-2019

enthalten in: Emerging infectious diseases | 2022

von Kherabi, Y. | Fréchet-Jachym, M. | Rioux, C. | +26

4

Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis : A 12-Year Case Series from France

enthalten in: Microorganisms | 2022

von Bonnet, I. | Haddad, E. | Guglielmetti, L. | +31

5

Active tuberculosis, sequelae and COVID-19 co-infection : first cohort of 49 cases

enthalten in: The European respiratory journal | 2020

von Tadolini, M. | Codecasa, L. | García-García, J. | +43

CommentIn: Eur Respir J. 2020 Jul 9;56(1):. - PMID 32444399

6

Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis

enthalten in: Emerging infectious diseases | 2019

von Mbuagbaw, L. | Guglielmetti, L. | Hewison, C. | +12

7

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis : an individual patient data meta-analysis

enthalten in: Lancet (London, England) | 2018

von Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017 | Ahmad, N. | Ahuja, S. | +98

CommentIn: Lancet. 2018 Sep 8;392(10150):797-798. - PMID 30215367

8

QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe : a Tuberculosis Network European Trialsgroup (TBnet) study

enthalten in: The European respiratory journal | 2018

von Guglielmetti, L. | Tiberi, S. | Burman, M. | +66

9

Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis : a case series from France and Latvia

enthalten in: The European respiratory journal | 2018

von Guglielmetti, L. | Barkane, L. | Le Dû, D. | +7

10

Reply : Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria

enthalten in: American journal of respiratory and critical care medicine | 2017

von van Leth, F. | Günther, G. | Hoffmann, H. | +43

CommentOn: Am J Respir Crit Care Med. 2016 Oct 15;194(8):1029-1031. - PMID 27685538